Segment disclosures

Company overview

Health-Right Discoveries, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

10 dimension combinations 79 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Ancillary Program

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cik0001537663:AncillaryProgramMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-311444060 USD20180511Open filing evidence
2017-01-01 – 2017-12-311599652 USD20180417Open filing evidence

Prescription Medicine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cik0001537663:PrescriptionMedicineMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31480772 USD20180511Open filing evidence
2017-01-01 – 2017-12-31452700 USD20180417Open filing evidence

Ancillary Program

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-30250946 USD20201118Open filing evidence
2020-01-01 – 2020-09-30844644 USD20201118Open filing evidence
2020-04-01 – 2020-06-30288010 USD20200814Open filing evidence
2020-01-01 – 2020-06-30593698 USD20200814Open filing evidence
2020-01-01 – 2020-03-31305688 USD20200513Open filing evidence
2019-01-01 – 2019-12-312792808 USD20200330Open filing evidence
2019-07-01 – 2019-09-30658970 USD20201118Open filing evidence
2019-01-01 – 2019-09-302204414 USD20201118Open filing evidence
2019-04-01 – 2019-06-30722558 USD20200814Open filing evidence
2019-01-01 – 2019-06-301545444 USD20200814Open filing evidence
2019-01-01 – 2019-03-31822886 USD20200513Open filing evidence
2018-01-01 – 2018-12-314930352 USD20200330Open filing evidence

Ancillary Program · Billing Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember;srt:ProductOrServiceAxis=hrdv:BillingServicesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-314930352 USD20190412Open filing evidence

Ancillary Program · Consulting Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember;srt:ProductOrServiceAxis=hrdv:ConsultingServicesMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-30250946 USD20201118Open filing evidence
2020-01-01 – 2020-09-30844644 USD20201118Open filing evidence
2020-04-01 – 2020-06-30288010 USD20200814Open filing evidence
2020-01-01 – 2020-06-30593698 USD20200814Open filing evidence
2020-01-01 – 2020-03-31305688 USD20200513Open filing evidence
2019-01-01 – 2019-12-312792808 USD20200330Open filing evidence
2019-07-01 – 2019-09-30658970 USD20201118Open filing evidence
2019-01-01 – 2019-09-302204414 USD20201118Open filing evidence
2019-04-01 – 2019-06-30722558 USD20200814Open filing evidence
2019-01-01 – 2019-06-301545444 USD20200814Open filing evidence
2019-01-01 – 2019-03-31822886 USD20200513Open filing evidence
2018-01-01 – 2018-12-314930352 USD20200330Open filing evidence

Billing Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:BillingServicesMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-30250405 USD20201118Open filing evidence
2020-01-01 – 2020-09-30844644 USD20201118Open filing evidence
2020-04-01 – 2020-06-30288010 USD20200814Open filing evidence
2020-01-01 – 2020-06-30593698 USD20200814Open filing evidence
2020-01-01 – 2020-03-31305688 USD20200513Open filing evidence
2019-01-01 – 2019-12-312792808 USD20200330Open filing evidence
2019-07-01 – 2019-09-30658970 USD20201118Open filing evidence
2019-01-01 – 2019-09-302204414 USD20201118Open filing evidence
2019-04-01 – 2019-06-30722558 USD20200814Open filing evidence
2019-01-01 – 2019-06-301545444 USD20200814Open filing evidence
2019-01-01 – 2019-03-31822886 USD20200513Open filing evidence
2018-01-01 – 2018-12-314930352 USD20200330Open filing evidence
2018-07-01 – 2018-09-301083773 USD20191113Open filing evidence
2018-01-01 – 2018-09-304027735 USD20191113Open filing evidence
2018-04-01 – 2018-06-301499903 USD20190809Open filing evidence
2018-01-01 – 2018-06-302943962 USD20190809Open filing evidence
2018-01-01 – 2018-03-311444060 USD20190516Open filing evidence
2017-01-01 – 2017-12-311599652 USD20190412Open filing evidence

OTC And Prescription Medication

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:OTCAndPrescriptionMedicationMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-3093087 USD20201118Open filing evidence
2020-01-01 – 2020-09-30254569 USD20201118Open filing evidence
2020-04-01 – 2020-06-3085436 USD20200814Open filing evidence
2020-01-01 – 2020-06-30162023 USD20200814Open filing evidence
2020-01-01 – 2020-03-3176587 USD20200513Open filing evidence
2019-01-01 – 2019-12-31674853 USD20200330Open filing evidence
2019-07-01 – 2019-09-30169332 USD20201118Open filing evidence
2019-01-01 – 2019-09-30585148 USD20201118Open filing evidence
2019-04-01 – 2019-06-30194693 USD20200814Open filing evidence
2019-01-01 – 2019-06-30415816 USD20200814Open filing evidence
2019-01-01 – 2019-03-31221123 USD20200513Open filing evidence
2018-01-01 – 2018-12-311353571 USD20200330Open filing evidence
2018-07-01 – 2018-09-30278183 USD20191113Open filing evidence
2018-01-01 – 2018-09-301151555 USD20191113Open filing evidence
2018-04-01 – 2018-06-30392792 USD20190809Open filing evidence
2018-01-01 – 2018-06-30873372 USD20190809Open filing evidence
2018-01-01 – 2018-03-31480772 USD20190516Open filing evidence
2017-01-01 – 2017-12-31452700 USD20190412Open filing evidence

OTC And Prescription Medication · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:OTCAndPrescriptionMedicationMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-3092546 USD20201118Open filing evidence
2020-01-01 – 2020-09-30254569 USD20201118Open filing evidence
2020-04-01 – 2020-06-3085436 USD20200814Open filing evidence
2020-01-01 – 2020-06-30162023 USD20200814Open filing evidence
2020-01-01 – 2020-03-3176587 USD20200513Open filing evidence
2019-01-01 – 2019-12-31674853 USD20200330Open filing evidence
2019-07-01 – 2019-09-30169332 USD20201118Open filing evidence
2019-01-01 – 2019-09-30585148 USD20201118Open filing evidence
2019-04-01 – 2019-06-30194693 USD20200814Open filing evidence
2019-01-01 – 2019-06-30415816 USD20200814Open filing evidence
2019-01-01 – 2019-03-31221123 USD20200513Open filing evidence
2018-01-01 – 2018-12-316283923 USD20200330Open filing evidence

Prescription Medicine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:PrescriptionMedicineMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311353571 USD20190412Open filing evidence

Prescription Medicine · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hrdv:PrescriptionMedicineMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311353571 USD20190412Open filing evidence